We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
- Authors
Huuhtanen, R L; Wiklund, T A; Blomqvist, C P; Böhling, T O; Virolainen, M J; Tribukait, B; Andersson, L C
- Abstract
A small but not insignificant number of patients experience a prolonged survival after treatment of metastatic soft tissue sarcoma. This must be weighed against the majority of the patients who benefit little from the therapy, but nevertheless experience its side-effects. It would therefore be of utmost importance to be able to screen for those patients who respond to the treatment. Since proliferating cells are more sensitive to chemotherapy than non-proliferative cells, we measured the proliferation rate of the primary tumour of 55 soft tissue sarcoma patients with locally advanced or metastatic disease by determining the flow cytometric S phase fraction and immunohistochemical Ki-67 and cyclin A scores. S phase fraction or Ki-67 score did not predict chemotherapy response or progression-free survival. A high cyclin A score, however, correlated with a better chemotherapy response (P = 0.02) and longer progression-free survival time (P = 0.04). Our results suggest that a high cyclin A score predicts chemotherapy sensitivity.
- Publication
British journal of cancer, 1999, Vol 81, Issue 6, p1017
- ISSN
0007-0920
- Publication type
Journal Article
- DOI
10.1038/sj.bjc.6690801